Molecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer models.

Abstract

Anticancer activity showed no apparent correlation with drug effects on beta-tubulin isotypes and apoptotic markers. The mass spectrometry approach has potential for the discovery of proteomic biomarkers for drug sensitivity.